YY/T 0127.17-2014Biological evaluation of medical devices used in dentistry - Part 17: Mouse lymphoma cells(TK)gene mutation test (English PDF)
口腔医疗器械生物学评价 第17部分:小鼠淋巴瘤细胞(TK)基因突变试验
This is a limited preview
Buy now to download the full PDF (15 pages)
Need quotation for your management?
Get a formal quotation for YY/T 0127.17-2014 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
June 17, 2014
Implementation date
July 1, 2015
Scope
YY/T 0127.17-2014 is the English-translated version of 口腔医疗器械生物学评价 第17部分:小鼠淋巴瘤细胞(TK)基因突变试验.
YY/T 0127.17-2014 is the Chinese pharmaceutical industry standard that gives the mouse lymphoma cell thymidine kinase gene mutation test for the medical devices used in dentistry.
It is the seventeenth part of the YY/T 0127 series and sets out the cells and their culture, the preparation and the application of the test sample with and without metabolic activation, the operating steps, the treatment of the data and the criteria by which the result is judged positive or negative. Issued on 17 June 2014, it has applied since 1 July 2015.
Found what you need?
Document preview — YY/T 0127.17-2014
National Standard of the People's Republic of China
- ICS
- 11.060.10
- Classification
- C 33
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword
- 1 Scope
- 2 Normative references
- 3 Terms and Definitions
Foreword
This section is "Oral Biological evaluation of medical devices" series standard part of the standard. "Biological Evaluation of Medical Devices Oral series of standards" in the YY/T 0268 "Dentistry Oral Biological evaluation of medical devices Unit 1. Evaluation and testing "is the choice of oral biological evaluation of medical devices with the pilot project, as a guide standard.
--- YY/T 0127 oral medical equipment specific biological test method standards, where YY/T 0127 is divided into the following sections.
--- YY/T 0127.1 Test methods for dental materials biological hemolysis test;
--- YY/T 0127.2 Biological evaluation of medical devices oral Unit 2. Test methods for acute systemic toxicity test. Intravenous way;
--- YY/T 0127.3 Oral Biological evaluation of medical devices - Part 3. Application Test of the root canal;
--- YY/T 0127.4 Oral Biological evaluation of medical devices Unit 2. Biological test methods of dental materials Bone implants trials;
--- YY/T 0127.5 Oral Biological evaluation of medical devices - Part 5. inhalation toxicity test;
--- YY/T 0127.6 Biological Evaluation of Dental Materials Unit 2. Biological test methods of dental materials dominant lethal test;
--- YY/T 0127.7 Biological Evaluation of Dental Materials Unit 2. Biological test methods of dental materials Pulp and dentine usage test;
Biological Evaluation --- YY/T 0127.8 Dental Materials Unit 2. Biological test methods of dental materials subcutaneous implantation test;
--- YY/T 0127.9 Biological Evaluation of Dental Materials Unit 2. Biological test methods of dental materials cytotoxicity test. Joan Fat cover method and molecular filtration method;
--- YY/T 0127.10 Biological evaluation of medical devices oral Unit 2. Test methods for Salmonella typhimurium reply projections Variable test (Ames test);
--- YY/T 0127.11 dentistry for preclinical evaluation of biocompatibility of medical devices oral Unit 2. Dental Materials Standard Test Method for pulp capping test;
--- YY/T 0127.12 Dentistry Oral Biological evaluation of medical devices Module 2. Test methods micronucleus test;
--- YY/T 0127.13 Biological evaluation of medical devices oral Unit 2. Test methods oral mucosa irritation test;
--- YY/T 0127.14 Oral Biological evaluation of medical devices Unit 2. Test methods for acute oral systemic toxicity tests;
--- YY/T 0127.15 Biological evaluation of medical devices oral Unit 2. Test methods subacute and subchronic systemic toxicity Test. the oral route;
--- YY/T 0127.16 Oral Biological evaluation of medical devices Unit 2. Test methods for mammalian cells in vitro chromosomal Aberration test;
--- YY/T 0127.17 Oral Biological evaluation of medical devices - Part 17. mouse lymphoma cells (TK) gene mutation test. This section YY/T 0127 Part 19. This section drafted in accordance with GB/T 1.1-2009 given rules.
1 Scope
YY/T 0127 provisions of this part of the oral medical equipment mouse lymphoma cells (TK) gene mutation assay method comprising the step operation Step, data processing and results determined.
This section applies to the determination of mutagenicity of dental instruments.
2 Normative references
The following documents for the application of this document is essential. For dated references, only the dated version suitable for use herein Member. For undated references, the latest edition (including any amendments) applies to this document.
GB/T 16886.1 Biological evaluation of medical devices - Part 1. Evaluation of the risk management process and Test
GB/T 16886.3 Biological evaluation of medical devices - Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicity
GB/T 16886.12 Biological evaluation of medical devices - Part 12. Sample preparation and reference materials
3 Terms and Definitions
GB/T 16886.1, GB/T 16886.3 and GB/T 16886.12 defined and the following terms and definitions apply to this document.
3.1 Mutation frequency
The number of mutant cells observed divided by the number of viable cells.
3.2 Relative total growth
Treated longer than the number of cells increase cell growth and the negative control group over time, calculated relative suspension growth relative survival Rate product.
3.3 Relative suspension growth
The expression ratio of the number of cells treated with the growth end of the negative control group.
3.4 Vitality viability
After the expression of cell culture plates set when treated colony forming efficiency.
3.5 Relative survival
relativesurvival; RS Set processing cell colony forming efficiency when dealing with the end plate culture. Usually treated with the negative control group, the relative number of cell viability FIG.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 15 pages — is available in the English PDF.
Referenced standards
Normative references
- GB/T 16886.1Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
- GB/T 16886.3Biological evaluation of medical devices -- Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
- GB/T 16886.12Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
Similar standards
How to Download YY/T 0127.17-2014
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 16886.1-2022 — Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
GB/T 16886.12-2023 — Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
GB/T 16886.3-2019 — Biological evaluation of medical devices -- Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
Secure payment via Stripe
Payments accepted
YY/T 0127.17-2014
$145.00